Response of rat retinal capillary pericytes and endothelial cells to glucose

Journal of Ocular Pharmacology and Therapeutics

Volumn 27, Issue 1, 2011, Pages 7-15

  Makita, Jun ^a   Hosoya, Ken Ichi ^b   Zhang, Peng ^a   Kador, Peter F ^a,c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF TOYAMA   (Japan)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; CASPASE 3; COLLAGEN TYPE 1; GLUCOSE; GLUCOSE REGULATED PROTEIN 78; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL COMMUNICATION; COCULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIUM CELL; NONHUMAN; PERICYTE; PROTEIN EXPRESSION; RAT; TIME;

ANIMALS; BLOTTING, WESTERN; CAPILLARIES; CASPASE 3; CELL LINE, TRANSFORMED; COCULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; GLUCOSE; HEAT-SHOCK PROTEINS; NF-KAPPA B; PERICYTES; RATS; RATS, TRANSGENIC; RETINAL VESSELS; TIME FACTORS;

EID: 79951972785     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2010.0051     Document Type: Article

References (75)

1. Diabetes Control and Complications Trial Research Group. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Ophthalmology 102:647-661, 1995.
2. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317:703-713, 1998.
3. Kalichman, M.W., et al. Nerve conduction velocity, laser Doppler flow, and axonal caliber in galactose and streptozotocin diabetes. Brain Res. 810:130-137, 1998. (Pubitemid 29003398)
4. Cogan, D.G., et al. NIH conference. Aldose reductase and complications of diabetes. Ann. Intern. Med. 101:82-91, 1984.
5. Robison, W.G. Galactosemic animal models. In: Sima, A.A.F., and Shafir, E., eds. Aniaml Models in Diabetes A Primer, series: Frontiers in Aminal Diabetes Research. Amsterdam: Harwood Academic Publishers; 2000; p. 273-308.
6. Kador, P.F., and Kinoshita, J.H. Diabetic and galactosaemic cataracts. Ciba Found. Symp. 106:110-131, 1984.
7. Cusick, M., et al. Effects of aldose reductase inhibitors and galactose withdrawal on fluorescein angiographic lesions in galactose-fed dogs. Arch. Ophthalmol. 121:1745-1751, 2003.
8. Engerman, R.L., and Kern, T.S. Progression of incipient diabetic retinopathy during good glycemic control. Diabetes 36:808-812, 1987. (Pubitemid 17145301)
9. Davis, S., and Alonso, M.D. Hypoglycemia as a barrier to glycemic control. J. Diabetes Complications 18:60-68, 2004. (Pubitemid 38332953)
10. Reichard, P. A risk-benefit assessment of conventional versus intensive insulin therapy. Drug Saf. 10:196-202, 1994. (Pubitemid 24090435)
11. Early worsening of diabetic retinopathy in the diabetes control and complications trial. Arch. Ophthalmol. 116:874-886, 1998.
12. Chung, S.S., et al. Contribution of polyol pathway to diabetes-induced oxidative stress. J. Am. Soc. Nephrol. 14(8 Suppl 3):S233-S236, 2003.
13. Kador, P.F. Ocular pathology of diabetes mellitus. In: Tasma, W., and Jaeger, E.A., eds. Duane's Foundations for Clinical Ophthalmology, Vol. 3. Philadelphia: Lippincott Williams & Wilkins; 2008; Chapter 18, p. 84.
14. Obrosova, I.G. How does glucose generate oxidative stress in peripheral nerve? Int. Rev. Neurobiol. 50:3-35, 2002.
15. Nishikawa, T., et al. Impact of mitochondrial ROS production in the pathogenesis of insulin resistance. Diabetes Res. Clin. Pract. 77(Suppl 1):S161-S164, 2007.
16. Miwa, K., et al. The role of polyol pathway in glucose-induced apoptosis of cultured retinal pericytes. Diabetes Res. Clin. Pract. 60:1-9, 2003.
17. Murata, M., et al. Selective pericyte degeneration in the retinal capillaries of galactose-fed dogs results from apoptosis linked to aldose reductase-catalyzed galactitol accumulation. J. Diabetes Complications 16:363-370, 2002.
18. Ido, Y. Pyridine nucleotide redox abnormalities in diabetes. Antioxid. Redox. Signal. 9:931-942, 2007.
19. Liu, G., et al. Apoptosis induced by endoplasmic reticulum stress involved in diabetic kidney disease. Biochem. Biophys. Res. Commun. 370:651-656, 2008.
20. Mulhern, M.L., et al. The unfolded protein response in lens epithelial cells from galactosemic rat lenses. Invest. Ophthalmol. Vis. Sci. 47:3951-3959, 2006.
21. Ladiges, W.C., et al. Pancreatic beta-cell failure and diabetes in mice with a deletion mutation of the endoplasmic reticulum molecular chaperone gene P58IPK. Diabetes 54:1074-1081, 2005. (Pubitemid 40446321)
22. Ozawa, K., et al. The endoplasmic reticulum chaperone improves insulin resistance in type 2 diabetes. Diabetes 54:657-663, 2005. (Pubitemid 40322067)
23. Fox, T.E., et al. Diabetes alters sphingolipid metabolism in the retina: a potential mechanism of cell death in diabetic retinopathy. Diabetes 55:3573-3580, 2006. (Pubitemid 44923619)
24. Ye, R., et al. Grp78 heterozygosity promotes adaptive unfolded protein response and attenuates diet-induced obesity and insulin resistance. Diabetes 59:6-16, 2010.
25. Ikesugi, K., et al. Role of the unfolded protein response (UPR) in cataract formation. Exp. Eye Res.83:508-516, 2006.
26. Tsiotra, P.C., and Tsigos, C. Stress, the endoplasmic reticulum, and insulin resistance. Ann. N. Y. Acad. Sci. 1083:63-76, 2006.
27. Ozcan, U., et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313:1137-1140, 2006. (Pubitemid 44300242)
28. Ozcan, U., et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306:457-461, 2004. (Pubitemid 39372439)
29. Ni, M., and Lee, A.S. ER chaperones in mammalian development and human diseases. FEBS Lett. 581:3641-3651, 2007. (Pubitemid 47082516)
30. Lee, A.S. The glucose-regulated proteins: stress induction and clinical applications. Trends Biochem. Sci. 26:504-510, 2001.
31. Lee, A.S. The ER chaperone and signaling regulator GRP78/BiP as a monitor of endoplasmic reticulum stress. Methods 35:373-381, 2005. (Pubitemid 40445371)
32. Lindenmeyer, M.T., et al. Proteinuria and hyperglycemia induce endoplasmic reticulum stress. J. Am. Soc. Nephrol. 19:2225-2236, 2008.
33. Sheikh-Ali, M., et al. Hyperglycemia-induced endoplasmic reticulum stress in endothelial cells. Nutrition 26:1146-1150, 2010.
34. Li, J., et al. Endoplasmic reticulum stress is implicated in retinal inflammation and diabetic retinopathy. FEBS Lett. 583:1521-1527, 2009.
35. Abcouwer, S.F., et al. Response of VEGF expression to amino acid deprivation and inducers of endoplasmic reticulum stress. Invest. Ophthalmol. Vis. Sci. 43:2791-2798, 2002.
36. Li, B., et al. P58(IPK) inhibition of endoplasmic reticulum stress in human retinal capillary endothelial cells in vitro. Mol. Vis. 14:1122-1128, 2008.
37. Hata, N., et al. Increased expression of IRE1alpha and stress-related signal transduction proteins in ischemia-reperfusion injured retina. Clin. Ophthalmol. 2:743-752, 2008.
38. Doh, S.H., et al. Retinal ganglion cell death induced by endoplasmic reticulum stress in a chronic glaucoma model. Brain Res. 1308:158-166, 2010.
39. Shimazawa, M., et al. Involvement of ER stress in retinal cell death. Mol. Vis. 13:578-587, 2007.
40. Shimazawa, M., et al. Neuroprotective effects of minocycline against in vitro and in vivo retinal ganglion cell damage. Brain Res. 1053:185-194, 2005. (Pubitemid 41116804)
41. Inokuchi, Y., et al. Effect of an inducer of BiP, a molecular chaperone, on endoplasmic reticulum (ER) stress-induced retinal cell death. Invest. Ophthalmol. Vis. Sci. 50:334-344, 2009.
42. Yang, L.P., et al. Endoplasmic reticulum stress is activated in light-induced retinal degeneration. J. Neurosci. Res. 86:910-919, 2008.
43. Hirschi, K.K., and D'Amore, P.A. Pericytes in the microvasculature. Cardiovasc. Res. 32:687-698, 1996.
44. Cogan, D.G., and Kuwabara, T. The mural cell in perspective. Arch. Ophthalmol. 78:133-139, 1967.
45. Li, W., et al. Retinal capillary pericyte apoptosis in early human diabetic retinopathy. Chin. Med. J. (Engl). 110:659-663, 1997.
46. Kador, P.F., et al. Effect of galactose diet removal on the progression of retinal vessel changes in galactose-fed dogs. Invest. Ophthalmol. Vis. Sci. 43:1916-1921, 2002.
47. Neuenschwander, H., Takahashi, Y., and Kador, P.F. Dose-dependent reduction of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by the aldose reductase inhibitor M79175. J. Ocul. Pharmacol. Ther. 13:517-528, 1997.
48. Li, A.F., and Roy, S. High glucose-induced downregulation of connexin 43 expression promotes apoptosis in microvascular endothelial cells. Invest. Ophthalmol. Vis. Sci. 50:1400-1407, 2009.
49. Takamura, Y., et al. Role of the polyol pathway in high glucose-induced apoptosis of retinal pericytes and proliferation of endothelial cells. Invest. Ophthalmol. Vis. Sci. 49:3216-3223, 2008.
50. Dagher, Z., et al. Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy. Diabetes 53:2404-2411, 2004. (Pubitemid 39145596)
51. Adams, D.D. Autoimmune destruction of pericytes as the cause of diabetic retinopathy. Clin. Ophthalmol. 2:295-298, 2008.
52. Hammes, H.P. Pericytes and the pathogenesis of diabetic retinopathy. Horm. Metab. Res. 37(Suppl 1):39-43, 2005.
53. Kador, P.F., et al. Polyol formation in cell lines of rat retinal capillary pericytes and endothelial cells (TR-rPCT and TR-iBRB). J. Ocul. Pharmacol. Ther. 25:299-308, 2009.
54. Leal, E.C., et al. High glucose and oxidative/nitrosative stress conditions induce apoptosis in retinal endothelial cells by a caspase-independent pathway. Exp. Eye Res. 88:983-991, 2009.
55. Robison Jr., W.G., et al. Aldose reductase and pericyte-endothelial cell contacts in retina and optic nerve. Invest. Ophthalmol. Vis. Sci. 30:2293-2299, 1989.
56. Ansari, N.H., et al. Prevention of pericyte loss by trolox in diabetic rat retina. J. Toxicol. Environ. HealthA54:467-475, 1998. (Pubitemid 28532444)
57. Sima, A.A., Garcia-Salinas, R., and Basu, P.K. The BB Wistar rat: an experimental model for the study of diabetic retinopathy. Metabolism 32(7 Suppl 1):136-140, 1983. (Pubitemid 13077665)
58. Robison Jr., W.G., Laver, N.M., and Lou, M.F. The role of aldose reductase in diabetic retinopathy: prevention and intervention studies. Prog. Retin. Eye Res. 14:593-640, 1995.
59. Lorenzi, M. The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient. Exp. Diabetes Res. 2007:61038, 2007.
60. Kinoshita, J.H. Mechanisms initiating cataract formation. Proctor Lecture. Invest. Ophthalmol. 13:713-724, 1974.
61. Mizuno, A., Toshima, S., and Mori, Y. Confirmation of lens hydration by Raman spectroscopy. Exp. Eye Res. 50:647-649, 1990.
62. Robison Jr., W.G., Houlder, N., and Kinoshita, J.H. The role of lens epithelium in sugar cataract formation. Exp. Eye Res. 50:641-646, 1990.
63. Ikesugi, K., et al. Induction of endoplasmic reticulum stress in retinal pericytes by glucose deprivation. Curr. Eye Res. 31:947-953, 2006.
64. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329:977-986, 1993.
65. Li, B., et al. The role of endoplasmic reticulum stress in the early stage of diabetic retinopathy. Acta Diabetol. 2009 [Epub ahead of print]; DOI: 10.1007/s00592-009-0170-z.
66. 2+ signaling and mitochondrial Cyt c release in astrocytes following oxygen and glucose deprivation. J. Neurochem. 114:1436-1446, 2010.
67. Vonk, L.A., et al. Endoplasmic reticulum stress inhibits collagen synthesis independent of collagen-modifying enzymes in different chondrocyte populations and dermal fibroblasts. Biochem. Cell Biol. 88:539-552, 2010.
68. Voccoli, V., et al. Serum-withdrawal-dependent apoptosis of hippocampal neuroblasts involves Ca++ release by endoplasmic reticulum and caspase-12 activation. Brain Res. 1147:1-11, 2007. (Pubitemid 46574545)
69. Ito, Y., et al. Lig-8, a bioactive lignophenol derivative from bamboo lignin, protects against neuronal damage in vitro and in vivo. J. Pharmacol. Sci. 102:196-204, 2006.
70. Zhang, K., and Kaufman, R.J. Protein folding in the endoplasmic reticulum and the unfolded protein response. Handb. Exp. Pharmacol. (172):69-91, 2006.
71. Frand, A.R., Cuozzo, J.W., and Kaiser, C.A. Pathways for protein disulphide bond formation. Trends Cell Biol. 10:203-210, 2000. (Pubitemid 30193270)
72. Kim, I., Xu, W., and Reed, J.C. Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat. Rev. Drug Discov. 7:1013-1030, 2008.
73. Shiu, R.P., Pouyssegur, J., and Pastan, I. Glucose depletion accounts for the induction of two transformation-sensitive membrane proteinsin Rous sarcoma virus-transformed chick embryo fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 74:3840-3844, 1977.
74. Xu, C., Bailly-Maitre, B., and Reed, J.C. Endoplasmic reticulum stress: cell life and death decisions. J. Clin. Invest. 115:2656-2664, 2005.
75. Sukumari-Ramesh, S., et al. Astrocyte-derived glutathione attenuates hemin-induced apoptosis in cerebral microvascular cells. Glia 58:1858-1870, 2010.